Effect of Bright Light on Sex Hormones and Ovulation in Humans
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study investigated whether bright artificial light may influence menstrual cycle and ovulation conclusively, and what underlying hormonal changes for this effect are.
| Condition | Intervention |
|---|---|
|
Anovulation |
Procedure: Light therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Basic Science |
| Enrollment: | 27 |
| Study Start Date: | September 2003 |
| Study Completion Date: | April 2006 |
Several studies have shown a shortening of the menstrual cycle following light therapy in women with abnormally long menstrual cycles or with winter depression, which suggests that bright light may influence sex hormones and ovulation. The study was designed to investigate this possibility. Twenty-two women with slightly lengthened menstrual cycles and without clinically evident endocrine abnormalities completed a study lasting for two menstrual cycles separated by an off-protocol episode of at least 1 menstrual cycle. Bright light therapy was administered for a week at home during one experimental cycle, and dim light during another cycle (placebo-controlled, crossover, counter-balanced order). Daytime blood sampling and ultrasound scan were performed before and after a week of light therapy, on the ~7th and 14th days after menstruation onset. Ultrasound examination was repeated further to document ovulation. Serum was assayed for thyroid-stimulating hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol. The preliminary results were reported at the SLTBR meeting in June, 2005.
Eligibility| Ages Eligible for Study: | 19 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Age 19-40 years
- Mean menstrual cycle 28-38 days
- Good general health
- Generally normal sleep-wake regimen
- Motivated for free participation
Exclusion Criteria:
- Low cooperation
- Medications known to interfere with hormone release
- Clinically evident endocrine abnormalities including the signs of
- Hyperandrogenism
- Travel over several time zones during two months prior the study
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Outside In |
| ClinicalTrials.gov Identifier: | NCT00327366 History of Changes |
| Other Study ID Numbers: | M-s3 |
| Study First Received: | May 17, 2006 |
| Last Updated: | October 18, 2009 |
| Health Authority: | Russia: Ethics Committee |
Keywords provided by Russian Academy of Medical Sciences:
|
Menstrual Cycle Light Therapy Sex Hormones Ovulation |
Additional relevant MeSH terms:
|
Anovulation Ovarian Diseases Adnexal Diseases |
Genital Diseases, Female Gonadal Disorders Endocrine System Diseases |
ClinicalTrials.gov processed this record on May 19, 2013